NKGen Biotech, Inc.
NKGN
$0.1275
$0.00151.19%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 119.89% | -104.97% | 35.33% | -383.68% | -395.70% |
| Total Depreciation and Amortization | 10.67% | 9.03% | 7.24% | -1.96% | 1.35% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -145.64% | 299.67% | -143.39% | 2,938.98% | 3,200.36% |
| Change in Net Operating Assets | 67.21% | 131.38% | 953.24% | 299.15% | 429.57% |
| Cash from Operations | 14.68% | -8.48% | 17.91% | -26.95% | 15.20% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 11.76% | -- | -38.46% | 100.00% |
| Cash from Investing | -- | 11.76% | 369.23% | -260.00% | 100.00% |
| Total Debt Issued | -78.56% | 2.93% | -73.68% | -98.91% | 155.80% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -79.06% | -- | -- | 0.00% | 1,026.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 222.72% | -21.42% | -- | -- | -- |
| Cash from Financing | -68.51% | -3.38% | -27.91% | -132.78% | 135.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -101.22% | -93.78% | -98.73% | -29,300.00% | 2,901.48% |